Although open-heart surgery is a frequent treatment for heart disease, it remains extremely dangerous. Now groundbreaking research from Dr. Britta Hardy of Tel Aviv University's Sackler School of Medicine has shown the potential for an injected protein to regrow blood vessels in the human heart — eliminating the need for risky surgery altogether.

Infants and young children treated with heart drugs get the wrong dose or end up on the wrong end of medication errors more often than older children, according to research led by the Johns Hopkins Children’s Center published July 6 in Pediatrics.

Imagine new treatments for heart disease or muscle loss that direct the body to repair damaged tissue rather than helping it cope with a weakened condition.

Researchers at The University of Nottingham have been awarded £2.8 million by the Wellcome Trust to develop a new drug that could ease the suffering of hundreds of thousands of heart disease patients who are unable to take beta-blockers.

Scientists at The University of Manchester are striving to discover how the body's natural sugars can be used to create stem cell treatments for heart disease and nerve damage – thanks to a £370,000 funding boost.

University of Florida researchers have identified a gene variation in heart disease patients who appear especially vulnerable to the physical effects of mental stress — to the point where blood flow to the heart is greatly reduced.

Researchers at UT Southwestern Medical Center have for the first time used drug-treated blood stem cells to repair heart damage in an animal model, results that might point to methods for healing injuries from heart attacks or disease.

Heart damage due to blocked arteries remains the leading cause of disease and death in the Western world, but a Florida State University College of Medicine researcher is helping to open new pathways toward treating the problem.

Researchers in Italy report development of a new group of aspirin-like substances that may be safer and as effective as conventional aspirin for fighting heart disease, the leading cause of death in the developed world. Their study is scheduled for the March 27 issue of the ACS’ Journal of Medicinal Chemistry.

Heart disease is still a major killer, especially in the western world, but new therapies based on stem cells and other techniques could now be imminent.

Virginia Commonwealth University researchers have identified the role of a key enzyme called CEH in reducing heart disease, paving the way for new target therapies to reduce plaques in the arteries and perhaps in the future, help predict a patient's susceptibility to heart disease.

GP performance related payments for tackling heart disease are too complex. They should be simplified and based more on disease treatment and prevention and less on risk factor measurement, experts advise in this week's BMJ.